CLINICAL_TRIALS
trial_result
· 2019-04-04
Clinical Trial Update: Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy [Phase 2]
Summary
Phase 2 trial comparing lorcaserin to duloxetine for chemotherapy-induced peripheral neuropathy; status and results not yet reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Southeastern Regional Medical Center | Conditions: Chemotherapy-Induced Peripheral Neuropathy | Phase 2 | Status: UNKNOWN